Hamzehpour 2020.

Study name	Treatment of depressive symptoms in patients after coronary artery bypass graft surgery
Methods	RCT design: 2‐arm parallel‐group trial Total N randomised: 100 Length of follow‐up: no follow‐up Analysis: not specified
Participants	Location: Iran Number of study centres and setting: 1 Ayatollah Rouhani Hospital, Iran CAD criteria: undergoing coronary artery bypass graft surgery Depression criteria: unclear. Depression measured with BDI. ICD code stated in health conditions studied (F32.0) Major depressive disorder, single episode, mild Other entry criteria: willingness to participate in the study Exclusion criteria: cognitive impairment, history of substance use, bipolar disorder
Interventions	Intervention 1: bupropion 75 mg/d increased to 150 mg/d Intervention 2: unclear from text. Likely citalopram or escitalopram 5 mg/d increased to 20 mg/d Duration of treatment: 8 weeks
Outcomes	Primary: BDI measured at baseline and end of therapy; no other outcomes specified
Starting date	25 July 2020
Contact information	Romina Hamzehpour Ayatollah Rouhani Hospital, Daneshgah Square, Ganjafrooz Avenue T: +98 11 3233 8301 E: r.hamzehpour@mubabol.ac.ir
Notes